BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 15932532)

  • 1. Relationship between histopathological features of chemotherapy treated retinoblastoma and P-glycoprotein expression.
    Souza Filho JP; Martins MC; Caissie AL; Torres VL; Fernandes LH; Erwenne CM; Burnier MN
    Clin Exp Ophthalmol; 2005 Jun; 33(3):279-84. PubMed ID: 15932532
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Histopathological features and P-glycoprotein expression in retinoblastoma.
    Filho JP; Correa ZM; Odashiro AN; Coutinho AB; Martins MC; Erwenne CM; Burnier MN
    Invest Ophthalmol Vis Sci; 2005 Oct; 46(10):3478-83. PubMed ID: 16186322
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinicopathological parameters and expression of P-glycoprotein and MRP-1 in retinoblastoma.
    Kamburoğlu G; Kiratli H; Söylemezoğlu F; Bilgiç S
    Ophthalmic Res; 2007; 39(4):191-7. PubMed ID: 17596751
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Histopathologic findings in eyes with retinoblastoma treated only with chemoreduction.
    Demirci H; Eagle RC; Shields CL; Shields JA
    Arch Ophthalmol; 2003 Aug; 121(8):1125-31. PubMed ID: 12912690
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multidrug resistant proteins: P-glycoprotein and lung resistance protein expression in retinoblastoma.
    Krishnakumar S; Mallikarjuna K; Desai N; Muthialu A; Venkatesan N; Sundaram A; Khetan V; Shanmugam MP
    Br J Ophthalmol; 2004 Dec; 88(12):1521-6. PubMed ID: 15548804
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neoadjuvant/adjuvant treatment of high-risk retinoblastoma: a report from the German Retinoblastoma Referral Centre.
    Künkele A; Wilm J; Holdt M; Lohmann D; Bornfeld N; Eggert A; Temming P; Schulte JH
    Br J Ophthalmol; 2015 Jul; 99(7):949-53. PubMed ID: 25583279
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combined chemotherapy and local treatment in the management of intraocular retinoblastoma.
    Brichard B; De Bruycker JJ; De Potter P; Neven B; Vermylen C; Cornu G
    Med Pediatr Oncol; 2002 Jun; 38(6):411-5. PubMed ID: 11984802
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Postenucleation adjuvant chemotherapy with vincristine, etoposide, and carboplatin for the treatment of high-risk retinoblastoma.
    Kaliki S; Shields CL; Shah SU; Eagle RC; Shields JA; Leahey A
    Arch Ophthalmol; 2011 Nov; 129(11):1422-7. PubMed ID: 22084213
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Management and outcome of retinoblastoma with vitreous seeds.
    Manjandavida FP; Honavar SG; Reddy VA; Khanna R
    Ophthalmology; 2014 Feb; 121(2):517-24. PubMed ID: 24572675
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Outcomes of a two-drug chemotherapy regimen for intraocular retinoblastoma.
    Zage PE; Reitman AJ; Seshadri R; Weinstein JL; Mets MB; Zeid JL; Greenwald MJ; Strauss LC; Goldman S
    Pediatr Blood Cancer; 2008 Mar; 50(3):567-72. PubMed ID: 17729249
    [TBL] [Abstract][Full Text] [Related]  

  • 11. De novo intraocular retinoblastoma development after chemotherapy in patients with hereditary retinoblastoma.
    Schueler AO; Anastassiou G; Jurklies C; Havers W; Wieland R; Bornfeld N
    Retina; 2006 Apr; 26(4):425-31. PubMed ID: 16603962
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neoadjuvant chemotherapy for extensive unilateral retinoblastoma.
    Bellaton E; Bertozzi AI; Behar C; Chastagner P; Brisse H; Sainte-Rose C; Doz F; Desjardins L
    Br J Ophthalmol; 2003 Mar; 87(3):327-9. PubMed ID: 12598448
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of C-kit in retinoblastoma: a potential therapeutic target.
    Barry RJ; de Moura LR; Marshall JC; Fernandes BF; Orellana ME; Antecka E; Martins C; Burnier MN
    Br J Ophthalmol; 2007 Nov; 91(11):1532-6. PubMed ID: 17591671
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development of new retinoblastomas after 6 cycles of chemoreduction for retinoblastoma in 162 eyes of 106 consecutive patients.
    Shields CL; Shelil A; Cater J; Meadows AT; Shields JA
    Arch Ophthalmol; 2003 Nov; 121(11):1571-6. PubMed ID: 14609913
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chemoreduction improves eye retention in patients with retinoblastoma: a report from the German Retinoblastoma Reference Centre.
    Künkele A; Jurklies C; Wieland R; Lohmann D; Bornfeld N; Eggert A; Schulte JH
    Br J Ophthalmol; 2013 Oct; 97(10):1277-83. PubMed ID: 23863458
    [TBL] [Abstract][Full Text] [Related]  

  • 16. What is the best treatment for retinoblastoma?
    Harbour JW
    Am J Ophthalmol; 2004 Sep; 138(3):471-3. PubMed ID: 15364232
    [No Abstract]   [Full Text] [Related]  

  • 17. A 10-year experience of outcome in chemotherapy-treated hereditary retinoblastoma.
    Bartuma K; Pal N; Kosek S; Holm S; All-Ericsson C
    Acta Ophthalmol; 2014 Aug; 92(5):404-11. PubMed ID: 24119165
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Causes of chemoreduction failure in retinoblastoma and analysis of associated factors leading to eventual treatment with external beam radiotherapy and enucleation.
    Gündüz K; Günalp I; Yalçindağ N; Unal E; Taçyildiz N; Erden E; Geyik PO
    Ophthalmology; 2004 Oct; 111(10):1917-24. PubMed ID: 15465557
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Results of combined chemotherapy and local ophtalmic therapy of children with intraocular retinoblastoma].
    Balwierz W; Kobylarz J; Starzycka M; Dluzniewska A
    Med Wieku Rozwoj; 2001; 5(3 Suppl 1):15-23. PubMed ID: 12004148
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A single-arm study of systemic and sub-Tenon chemotherapy for Groups C and D intraocular retinoblastoma: A Children's Oncology Group study (ARET 0231).
    Jubran RF; Villablanca JG; Krailo M; Piao J; Huang L; Murphree AL; O'Brien J; Gombos D; Shields CL; Meadows A; Chintagumpala M
    Pediatr Blood Cancer; 2020 Sep; 67(9):e28502. PubMed ID: 32589362
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.